Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:276-278
Published online before print January 10, 2008, doi: 10.1161/STROKEAHA.107.511717
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/2/276    most recent
STROKEAHA.107.511717v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorensen, A. G.
Right arrow Articles by Heiss, W.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorensen, A. G.
Right arrow Articles by Heiss, W.-D.
Related Collections
Right arrow Other imaging

(Stroke. 2008;39:276.)
© 2008 American Heart Association, Inc.


Advances in Stroke 2007

Advances in Imaging 2007

A. Gregory Sorensen, MD Wolf-Dieter Heiss, MD

From the Massachusetts General Hospital and Harvard Medical School (A.G.S.), Boston, Mass; and the Max Planck Institute for Neurological Research (W.-D.H.), Cologne, Germany.

Correspondence to A. Gregory Sorensen, MD, A.A. Martinos Center for Biomedical Imaging, 149 13th Street, Boston, Mass 02129. E-mail sorensen@nmr.mgh.harvard.edu


Key Words: imaging


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Imaging continues to be a mainstay of stroke diagnosis, management, and investigation, and this was fully evident again in 2007. Stroke continues to command a substantial amount of attention from investigators from a wide variety of disciplines. A broad range of insights and innovations in imaging have occurred in the past year, and the space allotted here remains too small to capture the range of efforts. In this survey we will discuss the ongoing advances in optimal imaging of the acute stroke patient, the role of imaging as a biomarker or surrogate end point, as well as efforts to use imaging to assess the risk of hemorrhage after chemical thrombolysis. Important data about the frequency of incidental stroke have been published. And, in a special focus, we will describe the role imaging has played this past year in building understanding of recovery from stroke.

One ongoing area of investigation regards the manner in which to optimally image the acute stroke patient. Guidelines issued this year1 provide an excellent summary: x-ray computed tomography (CT) guides most treatment decisions, and therapy should not be delayed to obtain multimodal imaging studies. However, multimodal imaging with CT and with MRI may provide additional information that will improve the diagnosis of acute ischemic stroke. Indeed, recent data suggest that CT angiography and perfusion assessment with CT is both feasible and in the specific setting of hemispheric stroke can provide assessment of vessel status such as site of occlusion, tissue damaged and potentially at risk, and . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Arch NeurolHome page
O. Ozdemir, V. Beletsky, R. Chan, and V. Hachinski
Thrombolysis, Fluctuations, and Protocol Expansions--Reply
Arch Neurol, March 1, 2009; 66(3): 418 - 419.
[Full Text] [PDF]